Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Telmikind Beta 40mg/25mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Mankind Pharma Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (25mg)

Overview Telmikind Beta 40mg/25mg Tablet ER

Telmikind Beta 40mg/25mg Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. For consistent blood levels, take this medication with food daily, as prescribed. Continue treatment as directed; don't discontinue without consulting your doctor, as hypertension is often asymptomatic. Lifestyle modifications—regular exercise, weight management, and a balanced diet—further support blood pressure control. Adhere to your physician's instructions. Potential side effects include headache, fatigue, dizziness, hypotension (possibly with fainting), elevated potassium levels, shortness of breath, nausea, vomiting, abdominal discomfort, and weakness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise gradually from seated positions. Regular monitoring of blood pressure, kidney function, blood sugar, urea, and electrolytes may be required. Inform your doctor about existing liver or kidney conditions, pregnancy, or breastfeeding before starting treatment. Also disclose all other medications, particularly those for hypertension or heart disease.

Primary Ingredients of Telmikind Beta 40mg/25mg Tablet ER

No text provided to rephrase.

Uses of Telmikind Beta 40mg/25mg Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Telmikind Beta 40mg/25mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Telmikind Beta 40mg/25mg Extended-Release Tablets should be administered with food.

Common Side effects of Telmikind Beta 40mg/25mg Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Telmikind Beta 40mg/25mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. Administer Telmikind Beta 40mg/25mg Extended-Release Tablet with food.

How Telmikind Beta 40mg/25mg Tablet ER works:

Telmisartan and Metoprolol Succinate, combined as Telmikind Beta 40mg/25mg Extended-Release tablets, effectively reduce blood pressure.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol intake and Telmikind Beta 40mg/25mg Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Telmikind Beta 40mg/25mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Telmisartan/Hydrochlorothiazide 40mg/25mg tablets (Telmikind Beta) are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Telmikind Beta 40mg/25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Telmikind Beta 40mg/25mg extended-release tablets are considered safe for use in individuals with impaired renal function. No alteration of the Telmikind Beta 40mg/25mg extended-release tablet dosage is necessary.

LiverLiverCAUTION

Patients with liver impairment should use Telmikind Beta 40mg/25mg Extended-Release tablets cautiously. Dosage modification of Telmikind Beta 40mg/25mg Extended-Release tablets may be necessary; physician consultation is advised.

What if you forget to take Telmikind Beta 40mg/25mg Tablet ER :

Should you forget a dose of your Telmikind Beta 40mg/25mg Extended-Release tablet, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed one and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Telmikind Beta 40mg/25mg Tablet ER

LabelValue
Developing Habits No.
Type of Treatment Heart

FAQs on Telmikind Beta 40mg/25mg Tablet ER

Telmikind Beta 40mg/25mg ER Succinate tablets may cause dizziness, especially upon standing suddenly after lying down or sitting. To minimize this risk, rise slowly from a lying or sitting position.
Improving your lifestyle alongside Telmikind Beta 40mg/25mg Tablet ER Succinate use significantly benefits your health. Quitting smoking reduces heart attack and stroke risk. Weight management, through diet and exercise, is crucial. A healthy diet rich in fruits and vegetables, combined with regular physical activity, strengthens your heart and lowers cardiovascular risks.
Continue taking your Telmikind Beta 40mg/25mg Tablet ER as prescribed, even if you feel healthy. Abruptly stopping this medication could cause serious problems, including heart attack or stroke.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Telmikind Beta 40mg/25mg ...
98
MRP 120
18% off